SINO-OCEAN GP(03377): The hearing for the UK restructuring plan application has ended, and the court will reserve judgment on the outcome.
Ocean Group (03377) announced that its application for approval of the UK restructuring plan will be sought from January 15, 2025...
SINO-OCEAN GP (03377) announced that it is seeking approval for its restructuring plan in the UK. A hearing for the application will be held from January 15th to 20th, 2025. The English court reserves the right to make a judgment.
Related Articles
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.
Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
Huiyu Pharmaceutical (688553.SH) subsidiary's clinical trial application for injection HY07121 (subcutaneous injection) has been accepted.
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.
Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
Huiyu Pharmaceutical (688553.SH) subsidiary's clinical trial application for injection HY07121 (subcutaneous injection) has been accepted.
RECOMMEND
